Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ayala Pharmaceuticals Inc (EM) ADXS

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company’s lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.


EXPM:ADXS - Post by User

User Avatar Image
(187)
•••
  • coolfooldumbguyX
Post by coolfooldumbguyon Nov 18, 2019 10:24am
110 Views
Post# 30364181

still holding this stock

still holding this stockthis is my new one for this month,should do well with it,like my FCEL and GHSI before this one,so glta shreholders as we go back up to a DOLLAR.
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities